StageZero Life Sciences Ltd. - Enterprise Value
SZLSF
Price:
$0.001
Market Cap:
$123.53K
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise focused on the development and commercialization of proprietary molecular diagnostic tests. These tests are primarily designed for the early detection of diseases and to facilitate personalized health management, with a particular emphasis on oncology-related conditions within the United States and Canada. At the core of their offerings is the proprietary Sentinel Principle platform technology, which specializes in identifying novel biomarkers from whole blood samples. The company's lead product, Aristotle, is an innovative multi-cancer panel test capable of simultaneously screening for numerous cancer types from a...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2009-09-08
Stock Exchange
OTC
Ticker
SZLSF
PE Ratio
[-0.05]
ROE
[481.50%]
Current Ratio
[0.04]
Dividend Yield
[0%]
Enterprise Value
[1.91M]
Dividend History
The Enterprise Value as of July 2026 (TTM) for StageZero Life Sciences Ltd. (SZLSF) is 1.91M
According to StageZero Life Sciences Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.91M. This represents a change of -67.64% compared to the average of 5.90M of the last 4 quarters.
StageZero Life Sciences Ltd. (SZLSF) Historical Enterprise Value (quarterly & annually)
How has SZLSF Enterprise Value performed in the past?
The mean historical Enterprise Value of StageZero Life Sciences Ltd. over the last ten years is 6.91M. The current 1.91M Enterprise Value has changed 2.66% with respect to the historical average. Over the past ten years (40 quarters), SZLSF's Enterprise Value was at its highest in in the March 2021 quarter at 74.40M. The Enterprise Value was at its lowest in in the December 2015 quarter at 922.49K.
Average
6.91M
Median
4.23M
Minimum
796.04K
Maximum
23.19M
StageZero Life Sciences Ltd. (SZLSF) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of StageZero Life Sciences Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 766.84%
Maximum Annual Enterprise Value = 23.19M
Minimum Annual Increase = -139.68%
Minimum Annual Enterprise Value = 796.04K
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 6.19M | -61.07% |
| 2021 | 15.90M | -31.46% |
| 2020 | 23.19M | 637.44% |
| 2019 | 3.15M | -16.54% |
| 2018 | 3.77M | 6.12% |
| 2017 | 3.55M | -24.46% |
| 2016 | 4.70M | 414.34% |
| 2015 | 913.95K | -86.76% |
| 2014 | 6.90M | 766.84% |
| 2013 | 796.04K | -139.68% |
StageZero Life Sciences Ltd. (SZLSF) Average Enterprise Value
How has SZLSF Enterprise Value performed in the past?
The current Enterprise Value of StageZero Life Sciences Ltd. (SZLSF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.09M
5-year avg
10.44M
10-year avg
6.91M
StageZero Life Sciences Ltd. (SZLSF) Enterprise Value vs. Peers
How is SZLSF’s Enterprise Value compared to its peers?
StageZero Life Sciences Ltd.’s Enterprise Value is greater than Medigene AG (-3756530.00), greater than IDenta Corp. (1.21M), less than ModivCare Inc. (1.44B), less than MJardin Group, Inc. (163.58M), greater than Epigenomics AG (-8582395.00), less than Vaccinex, Inc. (8.54M), less than Cann American Corp. (4.35M), greater than InVitro International (416.83K), less than Anything Technologies Media, Inc. (2.66M), less than Enzolytics Inc. (3.89M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -3756530.00 | $38.17M | |
| 1.21M | $890.03K | |
| 1.44B | $215.31K | |
| 163.58M | $90.14K | |
| -8582395.00 | $1.00M | |
| 8.54M | $3.16M | |
| 4.35M | $4.35M | |
| 416.83K | $1.38M | |
| 2.66M | $1.44M | |
| 3.89M | $2.90M |
Build a custom stock screener for StageZero Life Sciences Ltd. (SZLSF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like StageZero Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
StageZero Life Sciences Ltd. (SZLSF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like StageZero Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is StageZero Life Sciences Ltd.'s Enterprise Value?
What is the highest Enterprise Value for StageZero Life Sciences Ltd. (SZLSF)?
What is the 3-year average Enterprise Value for StageZero Life Sciences Ltd. (SZLSF)?
What is the 5-year average Enterprise Value for StageZero Life Sciences Ltd. (SZLSF)?
How does the current Enterprise Value for StageZero Life Sciences Ltd. (SZLSF) compare to its historical average?